Opioid Analgesics: Rise and Fall of Ligand Biased Signaling and Future Perspectives in the Quest for the Holy Grail.

Breault É, Brouillette RL, Hébert TE, Sarret P, Besserer-Offroy É

Open source

DOI
10.1007/s40263-025-01172-w
Published
2025 Jun
Container
CNS drugs
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s40263-025-01172-w,
  title = {Opioid Analgesics: Rise and Fall of Ligand Biased Signaling and Future Perspectives in the Quest for the Holy Grail.},
  author = {Breault É and Brouillette RL and Hébert TE and Sarret P and Besserer-Offroy É},
  year = {2025},
  journal = {CNS drugs},
  doi = {10.1007/s40263-025-01172-w},
  url = {https://doi.org/10.1007/s40263-025-01172-w}
}

RIS

TY  - JOUR
TI  - Opioid Analgesics: Rise and Fall of Ligand Biased Signaling and Future Perspectives in the Quest for the Holy Grail.
AU  - Breault É
AU  - Brouillette RL
AU  - Hébert TE
AU  - Sarret P
AU  - Besserer-Offroy É
PY  - 2025
JO  - CNS drugs
DO  - 10.1007/s40263-025-01172-w
UR  - https://doi.org/10.1007/s40263-025-01172-w
ER  - 

APA

É, B., RL, B., TE, H., P, S., & É, B. (2025). Opioid Analgesics: Rise and Fall of Ligand Biased Signaling and Future Perspectives in the Quest for the Holy Grail.. CNS drugs. https://doi.org/10.1007/s40263-025-01172-w

Source records